Ken Fisher’s MMSI Holdings & Trades

First Buy
Q3 2015
Duration Held
41 Quarters
Largest Add
Q3 2015
+147,755 Shares
Current Position
221,609 Shares
$18.44 M Value

Ken Fisher's MMSI Position Overview

Ken Fisher (via Fisher Asset Management, LLC) currently holds 221,609 shares of Merit Medical Systems, Inc. (MMSI) worth $18.44 M, representing 0.01% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 41 quarters.

Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in MMSI, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 105,878 shares. Largest reduction occurred in Q4 2022, reducing 77,278 shares.

Analysis based on 13F filings available since 2013 Q2

Ken Fisher's Merit Medical Systems (MMSI) Holding Value Over Time

Track share changes against reported price movement

Quarterly Merit Medical Systems (MMSI) Trades by Ken Fisher

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2015 +147,755 New Buy 147,755 $23.91
Q4 2015 +23,232 Add 15.72% 170,987 $18.59
Q1 2016 +14,810 Add 8.66% 185,797 $19.70
Q3 2016 -40,417 Reduce 21.75% 145,380 $24.29
Q4 2016 -65,259 Reduce 44.89% 80,121 $26.50
Q1 2017 +41,119 Add 51.32% 121,240 $28.90
Q2 2017 +38,277 Add 31.57% 159,517 $38.15
Q3 2017 +13,241 Add 8.30% 172,758 $42.35
Q4 2017 +14,728 Add 8.53% 187,486 $43.20
Q1 2018 -9,281 Reduce 4.95% 178,205 $45.35
Q2 2018 -35,381 Reduce 19.85% 142,824 $51.20
Q3 2018 -22,200 Reduce 15.54% 120,624 $61.45
Q4 2018 +105,878 Add 87.78% 226,502 $55.81
Q1 2019 +21,182 Add 9.35% 247,684 $61.83
Q2 2019 +84,922 Add 34.29% 332,606 $59.56
Q3 2019 +23,369 Add 7.03% 355,975 $30.46
Q4 2019 +81,630 Add 22.93% 437,605 $31.22
Q1 2020 -20,115 Reduce 4.60% 417,490 $31.25
Q2 2020 -26,621 Reduce 6.38% 390,869 $45.65
Q3 2020 -60,465 Reduce 15.47% 330,404 $43.50
Q4 2020 -28,904 Reduce 8.75% 301,500 $55.51
Q1 2021 -26,896 Reduce 8.92% 274,604 $59.88
Q2 2021 +3,908 Add 1.42% 278,512 $64.66
Q3 2021 +35,745 Add 12.83% 314,257 $71.80
Q4 2021 +5,352 Add 1.70% 319,609 $62.30
Q1 2022 +18,717 Add 5.86% 338,326 $66.52
Q2 2022 +18,826 Add 5.56% 357,152 $54.27
Q3 2022 -14,211 Reduce 3.98% 342,941 $56.51
Q4 2022 -77,278 Reduce 22.53% 265,663 $70.62
Q1 2023 -13,301 Reduce 5.01% 252,362 $73.95
Q2 2023 -6,808 Reduce 2.70% 245,554 $83.64
Q3 2023 -8,342 Reduce 3.40% 237,212 $69.02
Q4 2023 -16,007 Reduce 6.75% 221,205 $75.96
Q1 2024 -5,622 Reduce 2.54% 215,583 $75.75
Q2 2024 -730 Reduce 0.34% 214,853 $85.95
Q3 2024 +6,837 Add 3.18% 221,690 $98.83
Q4 2024 +2,491 Add 1.12% 224,181 $96.72
Q1 2025 -1,884 Reduce 0.84% 222,297 $105.71
Q2 2025 -6,852 Reduce 3.08% 215,445 $93.48
Q3 2025 +6,164 Add 2.86% 221,609 $83.23

Ken Fisher's Merit Medical Systems Investment FAQs

Ken Fisher first purchased Merit Medical Systems, Inc. (MMSI) in Q3 2015, acquiring 147,755 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher has held Merit Medical Systems, Inc. (MMSI) for 41 quarters since Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher's largest addition to Merit Medical Systems, Inc. (MMSI) was in Q3 2015, adding 147,755 shares worth $3.53 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 221,609 shares of Merit Medical Systems, Inc. (MMSI), valued at approximately $18.44 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Merit Medical Systems, Inc. (MMSI) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ken Fisher's peak holding in Merit Medical Systems, Inc. (MMSI) was 437,605 shares, as reported at the end of Q4 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.